Thomas Schreitmüller

618 total citations
13 papers, 533 citations indexed

About

Thomas Schreitmüller is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Thomas Schreitmüller has authored 13 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Thomas Schreitmüller's work include Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Thomas Schreitmüller is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Thomas Schreitmüller collaborates with scholars based in Switzerland, Germany and Greece. Thomas Schreitmüller's co-authors include Wolfgang Gebhard, Elmar Wächter, Karl HOCHSTRASSER, Stefan Foser, K.A. Weyer, Elke Dietel, Georgios Bakalos, Peter W. M. Reisinger, K Hochstrasser and Dominik Heinzmann and has published in prestigious journals such as Analytical Biochemistry, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

Thomas Schreitmüller

13 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Schreitmüller Switzerland 10 284 125 116 110 85 13 533
Robert Hinderer United States 13 497 1.8× 125 1.0× 116 1.0× 199 1.8× 237 2.8× 14 754
Christoph Rösli Switzerland 8 245 0.9× 168 1.3× 137 1.2× 124 1.1× 56 0.7× 10 487
Chris Herring United Kingdom 4 428 1.5× 228 1.8× 95 0.8× 66 0.6× 50 0.6× 5 594
Jayesh J. Kattla Ireland 5 625 2.2× 145 1.2× 57 0.5× 93 0.8× 165 1.9× 6 750
Esther Llop Spain 18 642 2.3× 109 0.9× 148 1.3× 277 2.5× 128 1.5× 31 917
Takatoshi Kitada Japan 8 366 1.3× 83 0.7× 78 0.7× 176 1.6× 31 0.4× 10 478
Ling Y. Lee Australia 11 647 2.3× 97 0.8× 90 0.8× 187 1.7× 162 1.9× 12 745
Merrina Anugraham Switzerland 7 582 2.0× 79 0.6× 95 0.8× 200 1.8× 94 1.1× 8 664
Luísa Silva Portugal 5 369 1.3× 73 0.6× 42 0.4× 150 1.4× 58 0.7× 6 460
Angelita G. Utleg United States 10 441 1.6× 37 0.3× 76 0.7× 58 0.5× 137 1.6× 10 646

Countries citing papers authored by Thomas Schreitmüller

Since Specialization
Citations

This map shows the geographic impact of Thomas Schreitmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schreitmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schreitmüller more than expected).

Fields of papers citing papers by Thomas Schreitmüller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schreitmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schreitmüller. The network helps show where Thomas Schreitmüller may publish in the future.

Co-authorship network of co-authors of Thomas Schreitmüller

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schreitmüller. A scholar is included among the top collaborators of Thomas Schreitmüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schreitmüller. Thomas Schreitmüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Heinzmann, Dominik, et al.. (2019). Development pathways for subcutaneous formulations of biologics versus biosimilar development. Expert Review of Precision Medicine and Drug Development. 7(1). 62–69. 7 indexed citations
2.
Declerck, Paul, et al.. (2018). Monoclonal Antibody Biosimilars in Oncology: Critical Appraisal of Available Data on Switching. Clinical Therapeutics. 40(5). 798–809.e2. 20 indexed citations
3.
Schreitmüller, Thomas, et al.. (2018). Comparative Immunogenicity Assessment of Biosimilars. Future Oncology. 15(3). 319–329. 22 indexed citations
4.
Bakalos, Georgios & Thomas Schreitmüller. (2017). Reply to ‘Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’. ESMO Open. 2(4). e000281–e000281. 3 indexed citations
5.
Jackisch, Christian, Frank A. Scappaticci, Dominik Heinzmann, et al.. (2014). Neoadjuvant Breast Cancer Treatment as a Sensitive Setting for Trastuzumab Biosimilar Development and Extrapolation. Future Oncology. 11(1). 61–71. 33 indexed citations
6.
Foser, Stefan, et al.. (2003). Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS). Protein Expression and Purification. 30(1). 78–87. 141 indexed citations
7.
Schreitmüller, Thomas, et al.. (1999). Sample Preparation for Peptide Mapping— A Pharmaceutical Quality-Control Perspective. Analytical Biochemistry. 266(1). 31–47. 123 indexed citations
8.
Gebhard, Wolfgang, et al.. (1990). Complementary DNA and deduced amino acid sequences of porcine α1‐microglobulin and bikunin. FEBS Letters. 269(1). 32–36. 14 indexed citations
9.
Gebhard, Wolfgang, Thomas Schreitmüller, Karl HOCHSTRASSER, & Elmar Wächter. (1989). Two out of the three kinds of subunits of inter‐α‐trypsin inhibitor are structurally related. European Journal of Biochemistry. 181(3). 571–576. 49 indexed citations
10.
Gebhard, Wolfgang, Thomas Schreitmüller, Karl HOCHSTRASSER, & Elmar Wächter. (1988). Complementary DNA and derived amino acid sequence of the precursor of one of the three protein components of the inter‐α‐trypsin inhibitor complex. FEBS Letters. 229(1). 63–67. 46 indexed citations
11.
Gebhard, Wolfgang, et al.. (1988). Inter-alpha-trypsin inhibitor is a complex of three different protein species.. PubMed. 369 Suppl. 19–22. 2 indexed citations
12.
Schreitmüller, Thomas, K Hochstrasser, Peter W. M. Reisinger, Elmar Wächter, & Wolfgang Gebhard. (1987). cDNA Cloning of Human Inter-α-Trypsin Inhibitor Discloses Three Different Proteins. Biological Chemistry Hoppe-Seyler. 368(2). 963–970. 57 indexed citations
13.
Schreitmüller, Thomas, et al.. (1986). Die Primärstruktur der Hämoglobine von Eisbär(Ursus maritimus,Carnivora) und Kragenbär(Ursus tibetanus,Carnivora). Biological Chemistry Hoppe-Seyler. 367(1). 53–60. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Hinderer Breakdown of academic impact, for papers by Christoph Rösli Breakdown of academic impact, for papers by Chris Herring Breakdown of academic impact, for papers by Jayesh J. Kattla Breakdown of academic impact, for papers by Esther Llop Breakdown of academic impact, for papers by Takatoshi Kitada Breakdown of academic impact, for papers by Ling Y. Lee Breakdown of academic impact, for papers by Merrina Anugraham Breakdown of academic impact, for papers by Luísa Silva Breakdown of academic impact, for papers by Angelita G. Utleg
Rankless by CCL
2026